Discriminant validity of the Hospital Anxiety and Depression Scale, Beck Depression Inventory (II) and Beck Anxiety Inventory to confirmed clinical diagnosis of depression and anxiety in patients with chronic obstructive pulmonary disease

Authors

Tina Phan, Edith Cowan UniversityFollow
Owen Carter, Edith Cowan UniversityFollow
Claire Adams, Edith Cowan UniversityFollow
Grant Waterer
Li Ping Chung
Maxine Hawkins
Cobie Rudd, Edith Cowan UniversityFollow
Mel R. Ziman, Edith Cowan UniversityFollow
Natalie Strobel, Edith Cowan UniversityFollow

Author Identifier

Claire Adams
https://orcid.org/0000-0002-0667-8088

Document Type

Journal Article

Publisher

Sage Publications

Place of Publication

United Kingdom

School

School of Medical and Health Sciences

RAS ID

21817

Funders

Government of Western Australia, Department of Health (Grant number G1000794)

Comments

Phan, T., Carter, O., Adams, C., Waterer, G., Chung, L., Hawkins, M., ... Strobel, N. (2016). Discriminant validity of the Hospital Anxiety and Depression Scale, Beck Depression Inventory (II) and Beck Anxiety Inventory to confirmed clinical diagnosis of depression and anxiety in patients with chronic obstructive pulmonary disease. Chronic Respiratory Disease, 13(3), 220-228.

https://doi.org/10.1177/1479972316634604

Abstract

The objective of this study was to investigate the discriminant validity of commonly used depresson and anxiety screening tools in order to determine the most suitable tool for patients with chronic obstructive pulmonary disease (COPD). COPD patients (n = 56) completed the Hospital Anxiety and Depression Scale (HADS), Beck Depression Inventory (BDI-II) and Beck Anxiety Inventory (BAI). These scores were compared to confirmed clinical diagnosis of depression and anxiety using the Mini Neuropsychiatric Interview. HADS depression subscale (HADS-D) sensitivity/specificity was 78/81 %; BDI-II 89/77 %; HADS anxiety subscale (HADS-A) 71/81 %; and BAI 89/62 %. HADS-D sensitivity/specificity was improved (100/83%) with the removal of Q4 'I feel as if I am slowed down' and adjusted cut-off ( ≥. 5). Removal of BDI-II Q21 'Loss of interest in sex' with adjusted cut-off ≥ 12 resulted in similar improvement (100/79 %). No problematic items were identified for HADS-A or BAI. Previously reported low sensitivity/specificity of the HADS for COPD patients was not replicated. Furthermore, simple modifications of the HADS-D markedly improved sensitivity/specificity for depression. BDI-II, HADS-A and BAI produced acceptable sensitivity/specificity unmodified. Pending further research for COPD patients we recommend continued use of the HADS-A with standard cut-off ( ≥ 8) and removal of Q4 of the HADS-D with lower cut-off ≥ 5.

DOI

10.1177/1479972316634604

Related Publications

Phan, T. (2018). Breathing New Life: Investigating ways to improve the mental health of people living with chronic obstructive pulmonary disease in Western Australia. Retrieved from http://ro.ecu.edu.au/theses/2071

Creative Commons License

This work is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 4.0 License.